The Choice Between Persuading and Coercing Americans to Get Vaccinated Against COVID-19

Larkin, Paul J.

doi:10.2139/ssrn.3980956

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hispanics, unlike Black individuals, did not experience religious barriers, probably because the Pope and Catholic leaders from early on promoted the COVID-19 vaccine. 35 We did not find a significant association between the four disadvantaged groups and access barriers. Thus, access barriers did not seem to be a key obstacle for disadvantaged groups in our study, even in the early stage of COVID-19 vaccination.…”

Section: Perceived Barrierscontrasting

confidence: 62%

COVID-19 Vaccine Hesitancy: Disadvantaged Groups’ Experience with Perceived Barriers, Cues to Action, and Attitudes

Coman

Yamamoto

2022

Am J Health Promot

View full text Add to dashboard Cite

Purpose Drawing from the Health Belief Model, we explored how disadvantaged groups in the U.S., including Black, Hispanic, less educated and wealthy individuals, experienced perceived barriers and cues to action in the context of the COVID-19 vaccination. Design A cross-sectional survey administered in March 2021. Setting USA Subjects A national sample of U.S. residents (n = 795) recruited from Prolific. Measures Perceived barriers (clinical, access, trust, religion/spiritual), cues to action (authorities, social circles), attitudes toward COVID-19 vaccination. Analysis Factor analysis and Structural Equation Model (SEM) were performed in STATA 16. Results Black and less educated individuals experienced higher clinical barriers (CI [.012, .33]; CI [.027, .10]), trust barriers (CI [.49, .92]; CI [.057, .16]), and religious/spiritual barriers (CI [.28, .66]; CI [.026, .11]). Hispanics experienced lower levels of clinical barriers (CI [-.42, .0001]). Clinical, trust, and religious/spiritual barriers were negatively related to attitudes toward vaccination (CI [-.45, −.15]; CI [-.79, −.51]; CI [-.43, −.13]). Black and less educated individuals experienced fewer cues to action by authority (CI [-.47, −.083]; CI [-.093, −.002]) and social ties (CI [-.75, −.33]; CI [-.18, −.080]). Lower-income individuals experienced fewer cues to action by social ties (CI [-.097, −.032]). Cues from social ties were positively associated with vaccination attitudes (CI [.065, .26]). Conclusion Communication should be personalized to address perceived barriers disadvantaged groups differentially experience and use sources who exert influences on these groups.

show abstract

Section: Perceived Barrierscontrasting

confidence: 62%

COVID-19 Vaccine Hesitancy: Disadvantaged Groups’ Experience with Perceived Barriers, Cues to Action, and Attitudes

Coman

Yamamoto

2022

Am J Health Promot

View full text Add to dashboard Cite

show abstract

“…In April 2021, President Biden became more active in advocating for COVID-19 vaccination ( 191 ), setting a 70% national vaccination rate goal ( 192 ) by the 4th of July, 2021. After vaccine promotion comments by President Biden, Governor DeSantis, and other Republican Governors reduced or stopped promoting COVID-19 vaccination ( 193 ).…”

Section: Introductionmentioning

confidence: 99%

The shifting impact and response to COVID-19 in Florida

Rivkees

2024

Front. Public Health

View full text Add to dashboard Cite

The first cases of COVID-19 in Florida were diagnosed on March 1, 2020. Three years later, more than 7.3 million people have had COVID-19 in Florida, and more than 93,000 individuals have died from this illness. When considering the impact of COVID-19 on Florida, several key factors need to be considered, including that Florida was one of the most medically vulnerable states due to a substantial proportion of older individuals and those with underlying medical conditions. Florida also has a centralized Department of Health and Division of Emergency Management structure that facilitated response activities. Looking at the impact of COVID-19 on Florida, two distinct phases need to be considered: the pre-Delta variant phase from March 2020 to July 2021 and the Delta variant and beyond phase that began July 2021 and still continues. During the 16-month first phase, about 38,000 people died. Yet, 24,000 people died during the 5-months of the Delta variant wave from July to November 2021. During the Omicron waves that followed Delta, an additional 31,000 people died. Florida thus went from ranking 26th in death per capita in the United States at the end of the first phase to 10th a few months into the Delta wave and now ranks 8th. Why did these phases differ so dramatically in terms of mortality? During the first phase of the pandemic, adherence to established nonpharmacological and older adult protection measures was recommended. When COVID-19 vaccines became available in December 2020, there was an aggressive campaign to promote COVID-19 vaccination, and public acceptance was high. The second phase followed political opposition to CDC and public health expert guidelines, the rise of anti-vaccine sentiment and misinformation, and falling vaccination rates. These factors contributed to considerable population vulnerability to severe disease when the Delta variant hit. As the former State Surgeon General and Secretary of Health of Florida from June 2019 to September 2021, this report provides perspective on the shifting impact and response to COVID-19 in Florida, which is the third most populous state in the United States. This perspective shows the clear consequences of shifting from standard public health practices and vaccine promotion to attacks on public health and vaccines.

show abstract

The Choice Between Persuading and Coercing Americans to Get Vaccinated Against COVID-19

Cited by 2 publications

References 0 publications

COVID-19 Vaccine Hesitancy: Disadvantaged Groups’ Experience with Perceived Barriers, Cues to Action, and Attitudes

COVID-19 Vaccine Hesitancy: Disadvantaged Groups’ Experience with Perceived Barriers, Cues to Action, and Attitudes

The shifting impact and response to COVID-19 in Florida

Contact Info

Product

Resources

About